Cerity Partners
NUVB icon

Cerity Partners’s Nuvation Bio NUVB Stock Holding History

Cerity Partners’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$446K Sell
78,487
-15,476
-16% -$75.6K ﹤0.01% 2505
2026
Q1 		$403K Sell
93,963
-2,689
-3% -$15K ﹤0.01% 2415
2025
Q4 		$866K Sell
96,652
-1,231
-1% -$7.63K ﹤0.01% 1791
2025
Q3 		$362K Buy
97,883
+48,065
+96% +$131K ﹤0.01% 2164
2025
Q2 		$97.1K Buy
+49,818
New +$104K ﹤0.01% 2482
2025
Q1 		– Sell
-11,809
Closed -$31.1K – 2573
2024
Q4 		$31.1K Buy
+11,809
New +$30.4K ﹤0.01% 2391

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Cerity Partners's NUVB Position: Q2 2026 in Review

Cerity Partners reduced its Nuvation Bio (NUVB) stake by 16% in Q2 2026, selling an estimated $75.6K and leaving 78,487 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #2505.

Cerity Partners first reported a position in NUVB in Q4 2024 and has held it in 6 quarters since. The position peaked at $866K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Cerity Partners held 78,487 shares of Nuvation Bio worth $446K as of Q2 2026.
  • Cerity Partners sold 15,476 Nuvation Bio shares in Q2 2026, an estimated $75.6K.
  • Nuvation Bio made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2505 holding.
  • Cerity Partners first reported a position in Nuvation Bio in Q4 2024 and has held it in 6 quarters since.
  • Cerity Partners's Nuvation Bio position peaked at $866K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.